Buspirone augmentation of sertraline.
Menkes
D B
DB
D015057:1-Naphthylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D000856:Anorexia Nervosa / Q000188:drug therapy* / Q000523:psychology; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002065:Buspirone / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D020280:Sertraline
D000928:Antidepressive Agents; D015057:1-Naphthylamine; D020280:Sertraline; D002065:Buspirone